摘要: 在最老的老年人中治疗骨质疏松症和骨关节炎
Nicola Veronese1, Nicholas C Harvey2,3, René Rizzoli4
1Saint Camillus International, University of Health Sciences, Rome, Italy. nicola.veronese@unicamillus.org.
Drugs & aging
|February 24, 2025
概括
这项研究总结了骨质疏松症,关节炎和肌肉骨疾病的临床和经济方面. 它为执行人员提供了ESCEO最近的调查结果和建议的概述.
科学领域:
- 肌肉骨健康 肌肉骨健康
- 临床经济学 临床经济学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症,关节炎和肌肉骨疾病对全球健康构成重大挑战.
- 有效的管理需要考虑临床结果和经济影响.
- 欧洲骨质疏松症,骨关节炎和肌肉骨疾病临床和经济方面学会 (ESCEO) 提供专家指导.
研究的目的:
- 提供最新的研究和临床指导方针的执行总结.
- 巩固与医疗保健专业人员和政策制定者相关的关键发现.
- 要突出临床实践和经济考虑在肌肉骨健康的交叉点.
主要方法:
- 审查最近的科学文献和临床试验数据.
- 分析经济模式和医疗保健资源利用情况.
- 专家共识和指导方针的综合由ESCEO.
主要成果:
- 骨质疏松症和骨关节炎的诊断和治疗的关键进展.
- 对各种治疗干预措施的经济评估.
- 确定未得到满足的需求和未来的研究方向.
结论:
- 综合的临床和经济策略对于最佳管理肌肉骨疾病至关重要.
- 基于证据的建议旨在改善患者的治疗结果和医疗保健的可持续性.
- 持续的研究和合作对于解决这些疾病的负担至关重要.
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Alzheimer's Disease: Treatment
149
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
149
What is the Skeletal System?
52.1K
Overview
52.1K
The Effect of Aging on Tissues
2.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.0K
Parkinson's Disease: Treatment
185
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
185


